Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

January 2022

Inibizione della progressione del danno strutturale articolare con upadacitinib nell'artrite reumatoide: risultati a 1 anno dal programma SELECT di fase 3

Rheumatology (Oxford). 2021. Epub ahead of print. doi: 10.1093/rheumatology/keab861

Hall S,

Durez P,

Shaw T,

Li Y,

Chen S,

Song IH

Keywords:

JAK,
Updacitinib,
Phase 3,
Efficacy,
Radiographic